An adequate characterization and validation determined HNRNPC as a prognosis biomarker and immune infiltration-related m6A regulator in HCC by public databases, qRT-PCR and immunohistochemistry analysis. This evidence concerns the gene HNRNPC and hepatocellular carcinoma.